22 July 2024
22 July 2024
Article doesn't exist
New global projections and advances in HIV therapies are also on the agenda at the AIDS 2024 meeting.
Boehringer Ingelheim will sell an unbranded copycat of Humira through GoodRx for $550 in a two-pack form.
The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrepreneur Sean Parker to bolster cancer research efforts.
The Opdivo/Yervoy combination demonstrated statistically and clinically significant improvements in the Phase III CheckMate-9DW study.
The tablet is indicated for use in adults and children over 40kg in weight to treat HIV.
The application is supported by interim data from the Phase III DREAMM-7 and DREAMM-8 trials.
The latest financing brings the total capital raised by GRObio to $90m.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report provides a granular forecast growth analysis for both global and regional chronic kidney disease markets through 2033. Per our estimates, the sales of CKD therapeutics across the 7MM will grow at a CAGR of >19% between 2023 and 2033. The launch of eight oral pipeline agents and six injectable pipeline agents will be the main drivers of the CKD market across the 7MM.
Give your business an edge with our leading industry insights.
